Press release
US Cell & Gene Therapy Market Surges to Reach $25.58 Billion by 2028 - Exclusive Focused Reports by Arizton
US-cell-gene-therapy-market
The US cell and gene therapy market will grow at a compound annual growth rate (CAGR) of 41.25% during 2022-2028.
To Get a Glimpse of our Report, Download the Free Sample Report: https://www.focusreports.store/report/us-cell-gene-therapy-market-focused-insights
The US is the fastest-growing market for cell & gene therapy products globally. The cell & gene therapy market in the US is growing at a healthy rate due to the presence of advanced healthcare infrastructure, high acceptance of cell & gene therapies, and high per capita healthcare expenditure in different states of the US. Based on therapy, the gene therapy segment dominated the US cell & gene therapy market in 2022 with a share of 76.95%. However, this scenario is likely to change as the number of product introductions in gene therapy and better management of the process using advanced vectors will increase the adoption of gene therapy during the forecast period. As a result, the segment will grow to 94.69% in 2028.
Recent Developments
In November 2022, CSL announced that the US FDA approved HEMGENIX (etranacogene dezaparvovec-drlb) for appropriate adults with hemophilia B.
In November 2022, Tenaya Therapeutics received an Orphan Drug Designation from the US Food and Drug Administration for its Gene Therapy for Genetic Arrhythmogenic Right Ventricular Cardiomyopathy.
In November 2022, Sensorion announced that the US FDA granted rare pediatric disease designation to its lead therapy gene candidate, OTOF-GT.
In September 2022, bluebird bio announced the US FDA granted Accelerated Approval of SKYSONA (elivaldogene autotemcel) to slow the progression of neurologic dysfunction in boys of 4-17 years of age with early active cerebral adrenoleukodystrophy (CALD).
The Report Provides Focused Insights Across the Following Sections.
REPORT HIGHLIGHTS
SEGMENTATION & FORECAST
THE FOLLOWING MARKET SEGMENT ANALYSIS IS INCLUDED IN THIS REPORT
Product
Cell Therapy
Gene Therapy
Application
Oncology
Genetic Disorders
Others
End-user
Hospitals
Cancer Care Centers
Others
Competitive Landscape - Gene Therapies
• Key Vendors
• Novartis
• Gilead Sciences
• Amgen
• Roche
• bluebird bio Inc
Other Prominent Vendors
• Bristol-Myers Squibb (BMS)
• Legend Biotech
• UniQure NV
• Ferring Pharmaceuticals
Competitive Landscape - Cell Therapies
Key Vendors
• Organogenesis
• Vericel Corp
• Dendreon
• Mallinckrodt Plc
• Enzyvant
Other Prominent Vendors
• AVITA Medical
• Fibrocell
Key Emerging Investigational Vendors
• 4DMT
• Abeona Therapeutics
• Autolus Therapeutics
• Candel Therapeutics
• Castle Creek Biosciences
• Cellectis
• Evox Therapeutics
• Freeline Therapeutics
• Generation Bio
• GenSight Biologics
• Krystal Biotech
• MeiraGTx
Questions Answered in the Report
What was the value of the U.S. cell and gene therapy market in 2022?
What is the projected value of the U.S. cell and gene therapy market in 2028?
Which type of gene therapy are drug developers prioritizing?
Who are the leading players in the U.S. cell and gene therapy market?
About Focused Reports by Arizton
Welcome to Focused Reports, an esteemed Arizton Advisory & Intelligence subsidiary committed to delivering precise and insightful market research reports across all key geographies. Our unique selling proposition lies in our affordable pricing, accurate data, in-depth research, and presentation-ready reports. With us, expensive market research is a thing of the past. We aim to be strategic, providing valuable data. Focus Reports is where folks come to name their ideas, create a compelling brand and a great-looking website, and attract customers with digital and social marketing.
Contact Us:
Call: +1-312-235-2040
+1 302 469 0707
Mail:enquiry@focusreports.com
Website: https://www.focusreports.store/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release US Cell & Gene Therapy Market Surges to Reach $25.58 Billion by 2028 - Exclusive Focused Reports by Arizton here
News-ID: 3445380 • Views: …
More Releases from Arizton Advisory & Intelligence
Exclusive Focus Insight Report by Arizton Predicts, the US Pool Maintenance and …
According to Arizton's latest focus research report, the US pool maintenance and cleaning service market is growing at a CAGR of 4.17% during 2023-2029.
To Know More, Click: https://www.focusreports.store/report/us-pool-maintenance-and-cleaning-services-market
The market is growing significantly due to advances in the pool technology, shift toward sustainability practices, rising popularity of subscription-based pool services, growing awareness of chemical balancing for above-ground pools, the growing demand for pool opening and closing services, the increasing demand…
The US Neonatal Incubators Market to Reach $121.11 Million by 2029 - Exclusive F …
According to Arizton's latest focus insight report, the US Neonatal incubators market is growing at a CAGR of 3.57% during 2023-2029.
To Know More, Click: https://www.focusreports.store/report/us-neonatal-incubators-market
The infant incubator market is highly fragmented, with many producers in the US. To meet the surging consumer demand and expand their customer base, these companies are implementing various tactics such as mergers & acquisitions, partnerships & collaborations, and new product launches. Owing to the…
The US Sleep Supplements Market to Reach $1.45 Billion by 2029 - Exclusive Focus …
According to Arizton's latest research report, the US sleep supplements market is growing at a CAGR of 5.97% during 2023-2029.
To Know More, Download the Free Sample Report: https://www.focusreports.store/report/us-sleep-supplements-market
The US sleep supplements market is growing significantly due to a surge in online sales and increasing demand for plant-based options. Lifestyle factors such as stress, irregular sleep patterns, and changing demographics, notably an aging population and health-conscious millennials, are driving this…
The Sale of Thailand Construction Equipment Market to Reach 22,586 Units by 2029 …
According to Arizton's latest research report, the Thailand construction equipment market is growing at a CAGR of 5.77% during 2023-2029.
To Know More, Click: https://www.arizton.com/market-reports/thailand-construction-equipment-market
Market Trends:
In January 2024, Thailand announced the launch of lithium production within two years from a new mine in the southwest part of the country. This aim is to support its goal of becoming a major regional hub for Electric Vehicle (EV) production. Establishing lithium…
More Releases for Gene
Competitive and Opportunities Analysis of Gene Therapy Market of Gene Therapy Ma …
Global Gene Therapy Market accounted for US$ 2.05 billion in 2020 and is estimated to be US$ 12.29 billion by 2030 and is anticipated to register a CAGR of 19.8%. Gene therapy means fixing a working gene to an individual who features a damaged gene. The European Commission has approved this method for one particular treatment. The treatment by the merchandise Glybera uses an epidemic to infect muscle cells with…
Genetic Testing Market Size by Growth Opportunities, Top Key Players: GeneDx, In …
Genetic Testing Market Report provides an in-depth analysis of the overall market, The ripple effect of Coronavirus-Covid19 on the market needs to become part of strategy discussions to emerge strong. The report focuses on major key players, production details, their application, countries and also analyzes the global and key regions market potential and advantage, opportunity, and challenge, restraints, and risks.
The Top players Covered in report are GeneDx, Invitae, Pathway Genomics,…
Gene Synthesis Market by Top Manufacturers - Gene script, Gene Art (Thermofische …
The "Gene Synthesis Market" report Added by "Big Market Research", enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies.
In the Gene Synthesis Market 2018 research report professionals describe the different facets of the industry with a specific goal…
Gene Therapy Market, by Gene Therapy Type Germline Gene Therapy and Somatic Gene …
Genes are composed of deoxyribonucleic acid (DNA), which contains essential information for producing proteins that are crucial for the optimal functioning of the body. Genetic disorder is the result of gene mutations in which proteins are made incorrectly. Gene therapy is intended to introduce healthy gene into damaged cells to counteract for abnormal genes or to make a protein of interest. Mutated gene causes missing of the important protein, with…
Gene Editing Market : A Market Study On Gene Editing And Cancer Therapy Techniqu …
Global Gene Editing Market
Precision Business Insights (PBI) in its report titled “Global Gene Editing Market : Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2017 and Forecast 2018-2027” assesses the market performance over 2018-2027. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.
Gene editing or Genome editing is…
Direct-to-consumer Genetic Testing Market: Top Players - Gene By Gene, MyHeritag …
Latest industry research report on: Global and United States Direct-to-consumer Genetic Testing Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts
This report studies the Direct-to-consumer Genetic Testing market status and outlook of global and major regions, from angles of players, regions, product and end Application/industries; this report analyzes the top players in global and major regions, and splits the Direct-to-consumer Genetic Testing market by product…
